Changes in Hong Kong stocks | Giant Biotech (02367) fell more than 3% at the end of the session, and the MSCI Index Double Eleven cosmetics category slowed down from 618

The Zhitong Finance App learned that Giants Biotech (02367) fell more than 3% at the end of the session. As of press release, it decreased by 3.52% to HK$19.74, with a turnover of HK$554.75,800.

According to the news, on November 12, MSCI announced the quarterly index adjustment results for November 2026. This adjustment will take effect after closing on November 30. Among them, 38 shares, including Giant Biotech, were excluded from the MSCI China Index.

In addition, data from the first phase of Double Eleven showed a 5% year-on-year increase in cosmetics GMV, which was better than the 2% growth rate in the general market, but it was significantly slower than 618 this year, and was mainly driven by platform discounts and leading KOLs. CMB International released a research report saying that the growth rate of Giant Biotech turned negative. The year-on-year decline in October was 7.0%, while the increase was 14.0% in September, mainly dragged down by Kefumei and Aotien channels.